rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Leo Furcht

Director

Company insider

Files Form 4 as: Director, Celcuity.

Every Form 4 they filed

In numbers

Trades disclosed
28
Buys
1
Sells
0
Bought
$103K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
16 May 2019
Last trade
7 Oct 2026
Last filed
9 Oct 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
CELC CelcuityDirector · Biotechnology · last 7 Oct 20261 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
7 Oct 2026filed 9 Oct 2026CELC CelcuityBiotechnologySEC FORM 4 Code M$1,900250 at $7.60filing
7 Oct 2026filed 9 Oct 2026CELC Celcuityoption or derivative · BiotechnologySEC FORM 4 Code M—250 at $0.00filing
5 Jun 2026filed 9 Jun 2026CELC CelcuityBiotechnologySEC FORM 4 Code A—1,530 at $0.00filing
5 Jun 2026filed 9 Jun 2026CELC CelcuityBiotechnologySEC FORM 4 Code A—1,530 at $0.00filing
4 Dec 2025filed 8 Dec 2025CELC Celcuityoption or derivative · BiotechnologySEC FORM 4 Code M—250 at $0.00filing
4 Dec 2025filed 8 Dec 2025CELC CelcuityBiotechnologySEC FORM 4 Code M$1,900250 at $7.60filing
19 May 2025filed 21 May 2025CELC Celcuityoption or derivative · BiotechnologySEC FORM 4 Code A—14,048 at $0.00filing
2 Dec 2024filed 3 Dec 2024CELC Celcuityoption or derivative · BiotechnologySEC FORM 4 Code M—250 at $0.00filing
2 Dec 2024filed 3 Dec 2024CELC CelcuityBiotechnologySEC FORM 4 Code M$900250 at $3.60filing
4 Jun 2024filed 6 Jun 2024CELC Celcuityoption or derivative · BiotechnologySEC FORM 4 Code A—8,153 at $0.00filing
28 Nov 2023filed 30 Nov 2023CELC Celcuityoption or derivative · BiotechnologySEC FORM 4 Code M—250 at $0.00filing
28 Nov 2023filed 30 Nov 2023CELC CelcuityBiotechnologySEC FORM 4 Code M$400250 at $1.60filing
22 May 2023filed 24 May 2023CELC CelcuityBiotechnologySEC FORM 4 Bought$103K10,000 at $10.32filing
15 May 2023filed 17 May 2023CELC Celcuityoption or derivative · BiotechnologySEC FORM 4 Code A—11,645 at $0.00filing
29 Nov 2022filed 6 Dec 2022CELC Celcuityoption or derivative · BiotechnologySEC FORM 4 Code M—250 at $0.00filing
29 Nov 2022filed 6 Dec 2022CELC CelcuityBiotechnologySEC FORM 4 Code M$400250 at $1.60filing
17 May 2022filed 19 May 2022CELC Celcuityoption or derivative · BiotechnologySEC FORM 4 Code D—500filing
17 May 2022filed 19 May 2022CELC Celcuityoption or derivative · BiotechnologySEC FORM 4 Code A—500filing
17 May 2022filed 19 May 2022CELC Celcuityoption or derivative · BiotechnologySEC FORM 4 Code D—500filing
17 May 2022filed 19 May 2022CELC Celcuityoption or derivative · BiotechnologySEC FORM 4 Code A—500filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

David W. GryskaDirector · Director at Celcuity, filing Form 4 there in the last year
Lance G. LaingChief Science Officer · Chief Science Officer at Celcuity, filing Form 4 there in the last year
Brian F. SullivanChief Executive Officer · Chief Executive Officer at Celcuity, filing Form 4 there in the last year
Vicky HahneChief Financial Officer · Chief Financial Officer at Celcuity, filing Form 4 there in the last year
BAKER BROS. ADVISORS LPDirector and 10% owner · Other at Celcuity, filing Form 4 there in the last year